We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

103 hedge funds and large institutions have $436M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,550% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 2

115% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 20

43% more funds holding

Funds holding: 72103 (+31)

26% more capital invested

Capital invested by funds: $345M → $436M (+$91.1M)

Holders
103
Holders Change
+31
Holders Change %
+43.06%
% of All Funds
3.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
43
Reduced
20
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
51
A.R.T. Advisors
New York
$939K +$562K +25,254 +121%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$816K +$884K +39,700 +13,233%
KIA
53
Kopp Investment Advisors
Minnesota
$815K -$130K -5,829 -13%
SIM
54
Spark Investment Management
New York
$771K +$111K +5,000 +15%
Nomura Holdings
55
Nomura Holdings
Japan
$734K +$473K +21,249 +144%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$716K +$200K +9,001 +34%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$676K +$90.1K +4,049 +14%
MC
58
Menta Capital
California
$622K -$13.4K -600 -2%
PAMU
59
Pictet Asset Management (UK)
United Kingdom
$592K +$73.5K +3,300 +13%
Two Sigma Advisers
60
Two Sigma Advisers
New York
$587K +$642K +28,822 New
GC
61
Globeflex Capital
California
$540K +$590K +26,500 New
Deutsche Bank
62
Deutsche Bank
Germany
$537K +$295K +13,269 +101%
KCM
63
Kingdon Capital Management
New York
$510K +$557K +25,000 New
DC
64
Deere & Company
Illinois
$504K +$550K +24,705 New
SCA
65
SAC Capital Advisors
Connecticut
$492K +$423K +18,994 +370%
Bank of America
66
Bank of America
North Carolina
$482K +$236K +10,609 +81%
TA
67
Teachers Advisors
New York
$470K +$24.7K +1,109 +5%
AllianceBernstein
68
AllianceBernstein
Tennessee
$458K -$24.8K -1,115 -5%
GA
69
Geneva Advisors
Illinois
$454K +$240K +10,780 +94%
Citadel Advisors
70
Citadel Advisors
Florida
$443K +$61.8K +2,778 +15%
EMG
71
Ellington Management Group
Connecticut
$418K +$145K +6,500 +46%
AQR Capital Management
72
AQR Capital Management
Connecticut
$403K +$440K +19,766 New
AI
73
Analytic Investors
California
$374K +$408K +18,315 New
IAM
74
Iridian Asset Management
Connecticut
$355K -$34.3K -1,540 -8%
CBOA
75
Commonwealth Bank of Australia
Australia
$330K +$360K +16,189 New

SGNT Hedge Fund Activity: Q3 2013 in Review

103 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2013, worth a combined $436M — up 26% from $345M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGNT positions and 2 closed out — a net gain of 31 holders — while 43 added to existing stakes and 20 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $87.9M. The largest seller was Deerfield Management, cutting an estimated $23.8M.

  • 103 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2013, up from 72 in Q2 2013.
  • Funds reported $436M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2013, up 26% quarter-over-quarter.
  • 33 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2013 and 2 closed out, a net change of +31 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2013 was Franklin Resources, an estimated $87.9M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2013 was Deerfield Management, an estimated $23.8M sold.

Based on aggregated 13F filings for Q3 2013.